Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. - Wikidata - awgldk - TriplyDB

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

http://www.wikidata.org/entity/Q36403093

about

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses Mechanism of dichotomy between CD8+ responses elicited by apoptotic and necrotic cells Murine models to evaluate novel and conventional therapeutic strategies for cancer Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy Dendritic-Tumor Fusion Cell-Based Cancer Vaccines Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment FADD: an endogenous inhibitor of RIP3-driven regulated necrosis Vaccines for pancreatic cancer Apoptotic cell clearance: basic biology and therapeutic potential.HDAC inhibitors and immunotherapy; a double edged sword?Photoreceptor cell death and rescue in retinal detachment and degenerations Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications Oncolytic viruses as anticancer vaccines T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?Autophagy, autophagy-associated adaptive immune responses and its role in hematologic malignancies The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck Tumor cell lysates as immunogenic sources for cancer vaccine design Primary sterile necrotic cells fail to cross-prime CD8(+) T cells Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism Cell death, clearance and immunity in the skeletal muscle Pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancer Primary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91 Chemo-immunotherapy with oxaliplatin and interleukin-7 inhibits colon cancer metastasis in mice Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy.Molecular mechanisms of ATP secretion during immunogenic cell death RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth.Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18.

P2860

Q21245463-0DEDE158-832A-493D-A3F0-7067F30F2E90 Q24596171-1F418BCB-A649-4213-B4BF-A48D607EDC97 Q24604495-7F06F031-622A-4D33-BE5F-21B11086D48E Q24629263-A2F85EE4-1672-4ED0-84F7-6A22A71257BC Q24673595-F11DAD5B-0CA5-490C-B838-91054D5E3062 Q26739959-C144E255-BFDB-433D-A2C0-9B57A63628DF Q26744827-3EBBCE5E-C8E7-4F4D-9CD6-256FA45D1D21 Q26765115-0A672CEB-D045-4D58-B076-D6D1A314EEC6 Q26765594-A33FCC6E-5759-4F6D-94C5-E3C549A3725B Q26766066-2D5700EC-D84D-44B6-9E11-DA05B4353018 Q26781215-00E24B2B-7A16-48E9-8D34-063D2C501B2F Q26782566-24EB2809-6DCE-4841-9B41-B56DB3F2DFF8 Q26799117-4A8A4DA6-21E7-40BD-9BA4-CE2C2164007F Q26823535-5AAAA4D4-5667-474B-A0E5-FA8E56BA697D Q26825850-3D7A9B47-209B-409F-B0A8-4000CD5BCBBB Q26825935-88F0AF3C-8473-4D77-BD7E-CBD5B5F1B05D Q26853102-338C3869-AFD7-4779-B77B-A295309A6E33 Q26853192-1189A252-A55B-4214-B699-9BE98A87C832 Q26996829-E9E8A301-92F0-4AD3-87EB-655425923B7A Q27004011-1E0B9E2F-0594-4229-B2DD-A9F4B740A31E Q27011510-69A6C115-A2EE-45BD-8F3A-C272FB045A1D Q27025600-CAA4258C-1288-44F5-A41E-9462FB03DE8A Q27335110-6206741B-F177-47DF-98E8-7E521DFA0A0E Q28072922-2A458FAF-D2C5-4B87-8129-98C5A9E5D467 Q28076473-83AE69FD-DE72-4E89-A0CF-DD9D119E8B96 Q28076894-9343A4A1-8694-4C07-8539-5C88B976314A Q28083469-223B38E4-D0D6-449C-A0F4-8CC38558D97F Q28279623-96A881DB-2A21-49CF-BC69-3015B2165862 Q28384980-C780AEC8-94DA-4912-8640-7940541853DF Q28386837-D67B2F8A-D2E6-4539-9F32-4A58174B7349 Q28392626-B9864833-6058-4EDC-957B-19ABBB2BBC55 Q28481417-FCF10A2B-3D60-4F2A-BE9C-1EEC05C5C19A Q28538913-9B9E8128-41D3-4119-A953-20688F088B3E Q30275792-80CC082C-C803-430D-AD6B-F6AF99B4B5BF Q30376149-24CAF96E-4F5D-4A1A-BEF6-9ABBDF863CA1 Q30408773-B1A6837D-35B9-4F7E-94A6-ADB9C0FB9E7F Q30679385-BBEB6985-5B98-4C1A-B543-9ADC118B363B Q33502208-B407E560-FCB1-4DC7-BAD9-F8C5D860A98F Q33517133-39C5B645-434A-45EC-9BE6-B6DFC62A61EF Q33552702-67AC0E5E-75EB-4A46-A9FF-50628FF5DC87

P2860

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

http://www.wikidata.org/entity/Q36403093

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

@ast

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

@en

type

label

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

@ast

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

@en

prefLabel

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

@ast

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

@en

P1433

Q36403093-9742949A-2ADE-4AF7-8D5B-6582D66B78D4

P1476

Q36403093-9601B519-B531-40E6-B69B-3025B8E1813F

P2093

Q36403093-010B0B6B-8194-4FC2-9DE2-D06F3803EC3A

Q36403093-060A1EAE-D606-4D1B-B610-46026535B1CA

Q36403093-24099C11-38C4-45B9-AC87-CC1ED970633C

Q36403093-257E035F-2A00-4D85-A76F-CC40EB6F7262

Q36403093-30BAE7D9-8466-46BC-9FAE-768653DE4E40

Q36403093-8A7A8535-048C-4B32-883A-DF1A6F43A3D1

Q36403093-9432696B-3AFE-4C57-93D0-DCB87B0E034E

Q36403093-AB19E916-4254-4473-8A89-307B9FA451BB

Q36403093-B7B97CAA-18AC-4730-9983-4A0ED2A78497

Q36403093-CE96EA77-3FEA-4D70-BB2A-A868ABF2879E

P2860

Q36403093-08F3FCFE-EBF5-42EE-AB5E-3CC8AFBC7A07

Q36403093-0C2F3784-A253-4E1B-9567-96C57A0AC676

Q36403093-0DB98899-290C-48D6-8500-1E5DC8DCA7AA

Q36403093-131B52E3-711F-47CE-82ED-6548854B555A

Q36403093-19FA07A4-B3AC-4B6D-B250-1EAB6B21C8BF

Q36403093-1A1704CE-1E65-446F-B336-A8B51AA93997

Q36403093-21E44A05-0205-47E0-8146-07111E30B077

Q36403093-28747172-A4A9-4694-B356-3E41FF586FBE

Q36403093-2967E7F1-E7FB-4A0F-AF56-2E9D58A56FD0

Q36403093-2A6430AF-A886-4BAC-A2F9-9931CEDEFEBC

P304

Q36403093-F392F369-41B7-4DA4-818E-FB0B6B75F546

P31

Q36403093-A5727967-339F-455F-9D9A-F33C3EAD3008

P356

Q36403093-018C9AF7-AEF6-491E-AFEB-D842F03B57DE

P407

Q36403093-2C12B282-3367-4521-8671-CDA7B0335AF2

P433

Q36403093-3EB5DBFC-02B8-4B6C-A442-5252A33E7C32

P478

Q36403093-B8F6E978-348C-41E6-9ECF-5DBADEC9ABB7

P50

Q36403093-40166A64-DC33-42D0-9E91-78D114586D01

Q36403093-4C7173E9-8FFD-470E-AD7D-2162351833BD

Q36403093-51B68FA6-8F4C-46C4-B3E6-7D9F46256509

Q36403093-833BAFE1-218B-4706-BE34-6A3BAEDFDD75

Q36403093-CA15604F-739F-4FE6-B7FA-4F84D4D82FB3

Q36403093-E5A61E66-0F75-462E-ABAC-066D9266FA57

P577

Q36403093-F2CB6889-5DDA-467C-AA84-6D57616C9D9F

P5875

Q36403093-B2B6EB4A-E743-4EC8-A623-648A333D8CF4

P698

Q36403093-EEFA16E5-9DC2-4020-8975-15224CE0785A

P932

Q36403093-11FF41DA-0D68-4009-BDAC-BD5FFB53005B

P356

P1433

Journal of Experimental Medicine

P1476

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

@en

P2093

Ahmed Hamai

http://www.w3.org/2001/XMLSchema#string

Carmen Garrido

http://www.w3.org/2001/XMLSchema#string

Didier Métivier

http://www.w3.org/2001/XMLSchema#string

Elise Schmitt

http://www.w3.org/2001/XMLSchema#string

Evelyne Pichard

http://www.w3.org/2001/XMLSchema#string

Frédéric Coutant

http://www.w3.org/2001/XMLSchema#string

Gérard Pierron

http://www.w3.org/2001/XMLSchema#string

Marie O Pequignot

http://www.w3.org/2001/XMLSchema#string

Michel Obeid

http://www.w3.org/2001/XMLSchema#string

Noelia Casares

http://www.w3.org/2001/XMLSchema#string

P2860

Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics

The induction of tolerance by dendritic cells that have captured apoptotic cells

Immune tolerance after delivery of dying cells to dendritic cells in situ

Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation

Dendritic cells and the control of immunity

The danger model: a renewed sense of self

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo

Death and anti-death: tumour resistance to apoptosis

Immune response against dying tumor cells

Immunotherapy: bewitched, bothered, and bewildered no more

P304

1691-1701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20050915

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P50

Laurence Zitvogel

Nathalie Chaput

François Ghiringhelli

Antoine Tesniere

Sandra Hervas-Stubbs

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7405762

http://www.w3.org/2001/XMLSchema#string

P698

16365148

http://www.w3.org/2001/XMLSchema#string

P932

2212968

http://www.w3.org/2001/XMLSchema#string